MX2007004535A - Antagonistas de integrinas bifenilicos. - Google Patents
Antagonistas de integrinas bifenilicos.Info
- Publication number
- MX2007004535A MX2007004535A MX2007004535A MX2007004535A MX2007004535A MX 2007004535 A MX2007004535 A MX 2007004535A MX 2007004535 A MX2007004535 A MX 2007004535A MX 2007004535 A MX2007004535 A MX 2007004535A MX 2007004535 A MX2007004535 A MX 2007004535A
- Authority
- MX
- Mexico
- Prior art keywords
- biphenyl
- integrin antagonists
- integrin
- antagonists
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
La siguiente invencion se dirige a compuestos farmaceuticos y composiciones de la Formula 1 (ver formula 1) utiles para tratar afecciones mediadas por la integrina av??3 y/o av??5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/033981 WO2006043930A1 (en) | 2004-10-14 | 2004-10-14 | Biphenyl integrin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007004535A true MX2007004535A (es) | 2007-06-08 |
Family
ID=34959012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007004535A MX2007004535A (es) | 2004-10-14 | 2004-10-14 | Antagonistas de integrinas bifenilicos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080064716A1 (es) |
EP (1) | EP1802618A1 (es) |
JP (1) | JP2008516947A (es) |
BR (1) | BRPI0419110A (es) |
CA (1) | CA2584041A1 (es) |
MX (1) | MX2007004535A (es) |
WO (1) | WO2006043930A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5637855B2 (ja) * | 2007-11-08 | 2014-12-10 | ザ ジェネラル ホスピタル コーポレイション | 蛋白尿症の治療のための方法及び組成物 |
PT3929196T (pt) | 2013-09-24 | 2023-09-11 | Fujifilm Corp | Composição farmacêutica de um novo composto contendo azoto ou seu sal, ou seu complexo de metal |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69706407T2 (de) * | 1996-03-29 | 2002-05-29 | Searle & Co | META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN |
DE19939981A1 (de) * | 1999-08-24 | 2001-03-01 | Merck Patent Gmbh | Neue Inhibitoren des Integrins alphavß3 |
JP2004521079A (ja) * | 2000-08-29 | 2004-07-15 | ファルマシア・コーポレーション | アルファーvベータ3アンタゴニストとして有用な二環式環系を含有する化合物 |
WO2002018340A1 (en) * | 2000-08-30 | 2002-03-07 | Pharmacia Corporation | GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
-
2004
- 2004-10-14 WO PCT/US2004/033981 patent/WO2006043930A1/en active Application Filing
- 2004-10-14 CA CA002584041A patent/CA2584041A1/en not_active Abandoned
- 2004-10-14 JP JP2007536666A patent/JP2008516947A/ja active Pending
- 2004-10-14 EP EP04795178A patent/EP1802618A1/en not_active Withdrawn
- 2004-10-14 MX MX2007004535A patent/MX2007004535A/es unknown
- 2004-10-14 US US11/576,584 patent/US20080064716A1/en not_active Abandoned
- 2004-10-14 BR BRPI0419110-2A patent/BRPI0419110A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1802618A1 (en) | 2007-07-04 |
JP2008516947A (ja) | 2008-05-22 |
WO2006043930A1 (en) | 2006-04-27 |
BRPI0419110A (pt) | 2007-12-11 |
US20080064716A1 (en) | 2008-03-13 |
CA2584041A1 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007011023A (es) | 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3. | |
EP1861399A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
TW200505903A (en) | CGRP receptor antagonists | |
TW200720260A (en) | Prokineticin 1 receptor antagonists | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
IL182317A0 (en) | Cgrp receptor antagonists | |
DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
EP1804919A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
DE602004013563D1 (de) | Rantagonisten | |
EA200870521A1 (ru) | Замещенные спироциклические антагонисты cgrp-рецепторов | |
WO2007079214A3 (en) | Prokineticin 2 receptor antagonists | |
MX2009000884A (es) | Derivados de piridizinona. | |
EP1615914A4 (en) | CGRP RECEPTOR ANTAGONISTS | |
MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
WO2006041830A3 (en) | Cgrp receptor antagonists | |
WO2007016087A3 (en) | Heterocyclic benzodiazepine cgrp receptor antagonists | |
MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
TW200745122A (en) | New compounds I | |
WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
TW200724140A (en) | Hydantoin compounds | |
EP1802372A4 (en) | CGRP RECEPTOR ANTAGONISTS) | |
MX2009006473A (es) | Inhibidores de receptor vainilloide de bencimidazol. | |
SG158091A1 (en) | Imidazoazepinone compounds | |
BRPI0516602A (pt) | composto, e, composição farmacêutica | |
GB0519760D0 (en) | Novel compounds |